• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压性心脏病的综合评估:聚焦心脏磁共振成像

Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus.

作者信息

Tadic Marijana, Cuspidi Cesare, Plein Sven, Milivojevic Isidora Grozdic, Wang Dao Wen, Grassi Guido, Mancia Giuseppe

机构信息

Department of Cardiology, University Hospital "Dr. Dragisa Misovic - Dedinje", Heroja Milana Tepica 1, Belgrade, 11000, Serbia.

University of Milan-Bicocca, Milan, Italy.

出版信息

Heart Fail Rev. 2021 Nov;26(6):1383-1390. doi: 10.1007/s10741-020-09943-x.

DOI:10.1007/s10741-020-09943-x
PMID:32170529
Abstract

Arterial hypertension represents the most frequent cardiovascular risk factor that is associated with cardiac remodeling. Hypertensive heart disease was defined by the presence of left ventricular hypertrophy (LVH) and diastolic dysfunction, and it has been diagnosed by echocardiography in everyday clinical practice. Interstitial myocardial fibrosis is the underlying cause of hypertension-induced cardiac remodeling, and it could not be visualized with different echocardiographic methods. Cardiac magnetic resonance (CMR) and its methods such as late gadolinium enhancement, and T1 mapping provides qualitative and quantitative assessment of interstitial myocardial fibrosis in hypertensive patients. Furthermore, CMR can provide differentiation of LVH between hypertensive patients and cardiomyopathies (hypertrophic or Fabry disease). Timely diagnosis of cardiac impairment and early treatment is essential because regression of LVH could be achieved with adequate treatment. Diffuse cardiac fibrosis in hypertensive patients might be an underlying mechanism that explains the increased cardiovascular morbidity and mortality in this population. Future longitudinal investigations are necessary to determine causal relationship between diffuse fibrosis and cardiovascular outcome in these patients. The aim of this review is to summarize the current knowledge regarding CMR techniques and their potential usage in patients with hypertensive heart disease.

摘要

动脉高血压是与心脏重塑相关的最常见心血管危险因素。高血压性心脏病的定义为存在左心室肥厚(LVH)和舒张功能障碍,在日常临床实践中通过超声心动图进行诊断。心肌间质纤维化是高血压诱导的心脏重塑的根本原因,不同的超声心动图方法无法对其进行可视化。心脏磁共振成像(CMR)及其延迟钆增强、T1映射等方法可对高血压患者的心肌间质纤维化进行定性和定量评估。此外,CMR可以区分高血压患者和心肌病(肥厚型或法布里病)之间的LVH。及时诊断心脏损伤并尽早治疗至关重要,因为通过适当治疗可使LVH消退。高血压患者的弥漫性心脏纤维化可能是解释该人群心血管发病率和死亡率增加的潜在机制。未来需要进行纵向研究以确定这些患者中弥漫性纤维化与心血管结局之间的因果关系。本综述的目的是总结关于CMR技术及其在高血压性心脏病患者中的潜在应用的当前知识。

相似文献

1
Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus.高血压性心脏病的综合评估:聚焦心脏磁共振成像
Heart Fail Rev. 2021 Nov;26(6):1383-1390. doi: 10.1007/s10741-020-09943-x.
2
T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.T1 Mapping在肥厚型表型鉴别中的应用:高血压性心脏病和肥厚型心肌病:国际T1多中心心血管磁共振研究结果
Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.115.003285.
3
Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes.高血压性心脏病左心室表型的综合特征分析
Heart. 2016 Oct 15;102(20):1671-9. doi: 10.1136/heartjnl-2016-309576. Epub 2016 Jun 3.
4
ECG strain pattern in hypertension is associated with myocardial cellular expansion and diffuse interstitial fibrosis: a multi-parametric cardiac magnetic resonance study.高血压患者的心电图应变模式与心肌细胞扩张和弥漫性间质纤维化相关:一项多参数心脏磁共振研究。
Eur Heart J Cardiovasc Imaging. 2017 Apr 1;18(4):441-450. doi: 10.1093/ehjci/jew117.
5
T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.T1 测量可识别肥厚型心肌病肌节突变携带者有无左心室肥厚的细胞外容积扩张。
Circ Cardiovasc Imaging. 2013 May 1;6(3):415-22. doi: 10.1161/CIRCIMAGING.112.000333. Epub 2013 Apr 2.
6
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.应用对比增强心脏磁共振成像对不同形式左心室肥厚相关重塑中纤维化进行无创检测。
J Am Coll Cardiol. 2009 Jan 20;53(3):284-91. doi: 10.1016/j.jacc.2008.08.064.
7
T₁ mapping detects pharmacological retardation of diffuse cardiac fibrosis in mouse pressure-overload hypertrophy.T₁ 映射可检测到药物对压力超负荷肥厚小鼠弥漫性心肌纤维化的抑制作用。
Circ Cardiovasc Imaging. 2014 Mar;7(2):240-9. doi: 10.1161/CIRCIMAGING.113.000993. Epub 2014 Jan 14.
8
Correlation between right ventricular T mapping and right ventricular dysfunction in non-ischemic cardiomyopathy.非缺血性心肌病中右心室T波映射与右心室功能障碍的相关性
Int J Cardiovasc Imaging. 2018 Jan;34(1):55-65. doi: 10.1007/s10554-017-1113-3. Epub 2017 Mar 29.
9
Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy.心血管磁共振在左心室肥厚鉴别诊断中的应用。
Curr Heart Fail Rep. 2020 Oct;17(5):192-204. doi: 10.1007/s11897-020-00481-z.
10
Relation of Myocardial Contrast-Enhanced T Mapping by Cardiac Magnetic Resonance to Left Ventricular Reverse Remodeling After Cardiac Resynchronization Therapy in Patients With Nonischemic Cardiomyopathy.非缺血性心肌病患者心脏再同步治疗后心脏磁共振心肌对比增强T成像与左心室逆向重构的关系
Am J Cardiol. 2017 May 1;119(9):1456-1462. doi: 10.1016/j.amjcard.2017.01.023. Epub 2017 Feb 9.

引用本文的文献

1
Trends analysis of the global burden of hypertensive heart disease from 1990 to 2021: a population-based study.1990年至2021年全球高血压性心脏病负担的趋势分析:一项基于人群的研究。
BMC Public Health. 2025 Jul 2;25(1):2233. doi: 10.1186/s12889-025-23389-6.
2
Predictive value of miR-637 for the occurrence of myocardial hypertrophy in patients with hypertension.miR-637对高血压患者心肌肥厚发生的预测价值。
J Cardiothorac Surg. 2025 Jun 24;20(1):270. doi: 10.1186/s13019-025-03517-4.
3
The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy.
心脏磁共振成像在肥厚型心肌病管理中的作用
J Cardiovasc Dev Dis. 2025 May 15;12(5):189. doi: 10.3390/jcdd12050189.
4
Cardiovascular magnetic resonance imaging markers of ageing: a multi-centre, cross-sectional cohort study.衰老的心血管磁共振成像标志物:一项多中心横断面队列研究。
Eur Heart J Open. 2025 May 2;5(3):oeaf032. doi: 10.1093/ehjopen/oeaf032. eCollection 2025 May.
5
The value of left ventricular T1 mapping and left atrial strain for distinguishing myocardial amyloidosis and hypertrophic cardiomyopathy.左心室T1映射和左心房应变在鉴别心肌淀粉样变性和肥厚型心肌病中的价值。
Int J Cardiovasc Imaging. 2025 Jul;41(7):1277-1286. doi: 10.1007/s10554-025-03410-0. Epub 2025 Apr 29.
6
Causal atlas on comorbidities in cardiomyopathy: a Mendelian randomization study of European ancestry.心肌病合并症的因果关系图谱:一项针对欧洲血统人群的孟德尔随机化研究
Clin Res Cardiol. 2025 Apr 14. doi: 10.1007/s00392-025-02647-y.
7
Left ventricle remodeling by CMR in treated patients with primary aldosteronism and primary systemic arterial hypertension.采用心脏磁共振成像评估原发性醛固酮增多症合并原发性系统性动脉高血压患者经治疗后的左心室重构情况。
PLoS One. 2024 Dec 23;19(12):e0316140. doi: 10.1371/journal.pone.0316140. eCollection 2024.
8
Discrimination of Left Atrial Strain Patterns in Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: a Cardiac Magnetic Resonance Feature.高血压性心脏病和肥厚型心肌病中左心房应变模式的鉴别:一项心脏磁共振特征
J Imaging Inform Med. 2025 Jun;38(3):1518-1530. doi: 10.1007/s10278-024-01293-6. Epub 2024 Oct 18.
9
Global prevalence and disability-adjusted life years of hypertensive heart disease: A trend analysis from the Global Burden of Disease Study 2019.高血压性心脏病的全球患病率和伤残调整生命年:来自 2019 年全球疾病负担研究的趋势分析。
J Glob Health. 2024 Aug 30;14:04172. doi: 10.7189/jogh.14.04172.
10
Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment.高血压性心脏病:机制、诊断与治疗
Rev Cardiovasc Med. 2024 Mar 6;25(3):93. doi: 10.31083/j.rcm2503093. eCollection 2024 Mar.